Philip Home is Professor of Diabetes Medicine at Newcastle University. His major research interest is new therapies for diabetes management, both insulin and oral agents – over 450 full length publications.
He was Consultant Physician in Newcastle and Vice-chair of the NICE Appraisal Committee, the UK drug reimbursement advisory committee (both to 2011), and has been Clinical Lead to UK and International Diabetes Federation guidelines. He was previously President of IDF Europe and Vice-President of the IDF.
He was the Programme Committee Chair for IDF World Diabetes Congress, Montreal, 2009 and the World Clinical Trials in Diabetes meeting, Vienna, 2018, and lectures widely internationally.
Dr. Rabaa Alhajeri holds a Bachelor’s degree in medicine, Irish Board in Family Practice, Arab Board in Family Medicine, and Diploma and Master degree in Diabetes.
She was a coordinator of central diabetes clinic in Primary Health Care and Public Health at Ministry of health from 2010 – 2015 Along with her 20-years-of-experience in Medicine, Dr. Al Hajeri a board member, Financial Secretary in Bahrain Diabetes Society and aboard member in gulf group for study of Diabetes Furthermore, she organized and facilitated various seminars and workshops in Diabetes prevention and complications. Dr Rabaa Alhajeri participated in many Diabetes conferences and she was a member in scientific committee of IMDO conference 2018 & 2019. Also, Dr Rabaa took part in numerous programs for promoting health care and diabetes awareness.
Dr. Eric Westman is an Associate Professor of Medicine at Duke University. Board Certified in Obesity Medicine and Internal Medicine, Dr. Westman founded the Duke Lifestyle Medicine Clinic in 2006 after 8 years of clinical research on low carbohydrate & ketogenic diets.
Dr. Westman combines clinical research and clinical care to deliver lifestyle treatments for obesity, diabetes and tobacco dependence. He is an internationally known researcher specializing in low-carbohydrate nutrition and is Past-President and Master Fellow of the Obesity Medicine Association and Fellow of The Obesity Society.
Dr. Westman is also an editor of the textbook “Obesity: Evaluation & Treatment Essentials”, and author of the New York Times Bestseller “The New Atkins for a New You”, “Cholesterol Clarity”, and “Keto Clarity”. He is the co-founder of several companies based on low carbohydrate concepts.
I am a fully qualified and licensed psychologist, with over 20 years of training and experience in academic and healthcare settings in the UK, the USA, Greece, South Africa, and Australia. I travel extensively, mostly for my research, which primarily examines behaviours in close sexual relationships, such as safer-sex, condom use, gender-based power imbalances, religiosity influences on sexual behaviour, and more. My research also explores risk-taking behaviours, such as bullying, alcohol and substance use; and other health-promoting behaviours, such as intermittent fasting and very low carbohydrate diets.
My research has been published in peer-reviewed journals and presented at international conferences.
I currently hold academic positions at the University of California, Merced; the Universities of Cape Town, South Africa; and Curtin, Australia. I am a Chartered Psychologist (CPsychol) and an Associate Fellow (AFBPsS) of the British Psychological Society (BPS). I've also been a member of the European Health Psychology Society (EHPS) and the UK Society of Behavioural Medicine (UKSBM).
While I prioritize my academic career, I wholeheartedly believe that the essence of being a psychologist is supporting others; offering a useful, pragmatic service to those around us. Therefore, in parallel with my academic career, I’ve trained in cognitive behavioural counselling and mindfulness, which I’ve practiced in clinical settings.
I am a Canadian-born Greek, who grew up in Canada and Greece but has travelled and lived around the world for study, work, and pleasure. I come from a traditional, close-knit family, which has nevertheless given me the skills to be a strong and independent citizen of the world.
Professor Per-Henrik Groop, MD, DMSc, FRCPE graduated from the University of Helsinki in 1982. It was here where he defended his thesis on 'The relationship between GIP and beta-cell function in man' in 1989. Following post-doctoral studies at Guy’s Hospital, University of London, under Professor Giancarlo Viberti, Professor Groop returned to Helsinki as Consultant of Nephrology. He served as Professor of Nephrology (Chair) 2010-2015 and is currently Professor of Internal Medicine (Chair) at the University of Helsinki. He is also Chief Physician at the Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital and Principal Investigator of the Finnish Diabetic Nephropathy (FinnDiane) Study at the Folkhälsan Research Center in Helsinki, Finland. He is Adjunct Professor at the Department of Diabetes, Monash University, Melbourne, Australia.
His research is focused on the dissection of the pathogenesis of diabetic complications with special emphasis on diabetic nephropathy. In order to provide a unique set of clinical resources with high power to identify genes and genetic variants associated with diabetic complications, Professor Groop initiated the large, nationwide FinnDiane Study in 1997. To date, this landmark study comprises 8400 patients with Type 1 Diabetes and their family members recruited via a comprehensive network of 92 hospitals and healthcare centres throughout Finland. His FinnDiane Research Group represents an inter-disciplinary team of 45 scientists, post-graduate students and personnel.
Professor Groop served as Associate Editor of Diabetologia, 2005–2007, and as member of the Advisory Board, 2008–2011. He served as Associate Editor of Kidney International and International Diabetes Monitor, 2007–2011. He was Chairman of the EASD Scientist Training Course, 2007–2013, President of the European Diabetic Nephropathy Study Group (EDNSG), 2008–2010, Chairman of the Signe and Ane Gyllenberg Foundation since 2011, and Honorary Secretary of the EASD 2013-2016. He was awarded the prestigious EASD Castelli Pedroli Prize – 24th Camillo Golgi Lecture in 2009 as well as the Novo Nordisk Foundation Lecture in 2012.
Professor Groop has published more than 350 peer-reviewed original articles in high-impact journals, 33 reviews and book chapters, 47 papers in his native languages Swedish and Finnish as well as more than 600 abstracts presented at major international meetings.
PROFESSOR ALLAN J. BRIMICOMBE
Centre for Geo-Information Studies, University of East London
1995 PhD Geographical Information Systems, University of Hong Kong.1985 MPhil Applied Geomorphology, University of Hong Kong.1976 BA (Hons) Geography, Sheffield University, UK.
2002 Chartered Geographer, C.Geog
2017 Justice of the Peace, JP
Data Science & Geo-Information Science:
Data quality issues; GIS and environmental simulation modelling, spatial decision support; spatial data analysis; geocomputational techniques, fuzzy concepts in GIS; location-based services; data mining and cluster detection. Deep maps.
Crime analysis: predictive analytics using crime data. Evaluation and impact studies.
Member of national and international professional and non professional diabetes associations, Chair of IDF Europe (1997- 2003), IDF Vice-president (2003-2009) , Chairman of the IDF Science TF (2009-2012). Founder of the Members of the European Parliament Diabetes Working Group.
Former member of the Faculty of Medicine and Chair of the Schools of Podology and of Nursing Sciences of the University of Perugia (I); Chair of the Umbria Regional Diabetes Reference Centre; Co-director of the WHO Collaborating Centre for Diabetes Care Improvement. Director of Research and Education at Dasman Institute for Diabetes Research (Kuwait, 2007-2009). At present, President of the HUB for International health ReSearch-HIRS.
Main areas of diabetes research: pathophysiology; new drugs; advanced systems for insulin delivery; complications; pregnancy; metabolic monitoring; epidemiology, diabetes registries; ethics. Member of EU projects EURODIABETA; DIABCARD 1-4; DIABCARE 1-3; MFIT; DIABSTYLE 1-2; ADICOL, IMMIDIAB, PARENT, CHRODIS, BRIDGE Health and Project leader of B.I.R.O. and EUBIROD.
Professor Apostolos Tsapas MD PhD MSc (Oxon) graduated from Aristotle University of Thessaloniki in 1992, and defended his thesis there in 2002. Following a fellowship (2007-2009) in diabetes at Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital, University of Oxford under Professor David R. Matthews, he studied for an MSc in Evidence-based healthcare at the Centre for Evidence Based Medicine (CEBM) at the University of Oxford in UK (2012). After a 6-month stay at the Knowledge and Evaluation Research Unit at Mayo Clinic Rochester MN USA with Professor Victor Montori, he returned to Greece in 2012. He is currently Professor of Medicine and Diabetes at Aristotle University of Thessaloniki, Head of the Second Medical Department and the Diabetes Centre at Ippokratio Hospital Thessaloniki, founding Lead Investigator of the Clinical Research and Evidence-Based Medicine Unit at Aristotle University of Thessaloniki, and senior research fellow at Harris Manchester College, University of Oxford, UK.
His research is focused on knowledge synthesis (systematic reviews and meta-analyses), evidence-based practice, patient-centred care and clinical decision-making in medicine and diabetes. Professor Tsapas has been involved in the development of the Hellenic diabetes guidelines (2018, 2019), and the joined American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) 2012, 2015, 2018 and 2019 position statements on the management of hyperglycaemia in type 2 diabetes. A diabetologist and health services researcher, Professor Tsapas is the author of more than 100 peer-reviewed publications, many of them in top-ranking medical journals (Lancet, BMJ, Annals of Internal Medicine, JAMA Internal Medicine, Lancet Diabetes Endocrinology).
Dr. Karadeniz has been actively involved in the field of diabetes for the past 20 years in a series of medical, scientific and social projects both at national and international levels.
She was the Consultant Ophthalmologist of the Diabetes Div. of Istanbul Medical Faculty of the Istanbul University between the years 1992-2004, of the Diabetes and Metabolism Research and Appl. Unit of the Institute for Experimental Medicine between the years 1994-2004, and a Faculty Member at the Ophthalmology Dept. of Medical Faculty of Istanbul Science University between the years 2006-2014.
Currently she is a Teaching Faculty at the Ophthalmology Dept. of Medical Faculty of Demiroglu Bilim University and also working as an ophthalmologist at the Ophthalmology Dept. of the Istanbul Florence Nightingale Hospital. As an ophthalmologist, she is also in the diabetes team at the International Diabetes Center of the Florence Nightingale Hospitals.
She is the Founding Member and the Board Member of the Turkish Diabetes Foundation (TURKDIAB).
She served as the President of the Living with Diabetes Association, a nationwide patients’ organisation, between the years 2004-2007, and also currently as of July 2019.
Dr. Karadeniz joined the board of International Diabetes Federation European Region (IDF Europe) in 2007, and served as the Chair of IDF Europe between Dec. 2015 and 2019.
She has also been a Council Member of EASD for the term 2014-2017.
Throughout the years her activities have mainly focused on improvement of outcomes in people with diabetes (primary and secondary prevention), advocacy, patients’ rights including the right to access to care, education and association development at the local, national, and international levels.
Dr. Ali Al Lawati is an Internal Medicine specialist practicing in Oman, where he was the first health care professional to officially prescribe the Low Carbohydrate/ketogenic lifestyle as a treatment for his patients. He is also a type-1 diabetic. He was diagnosed at the age of 7 and started treating his own diabetes with a Low Carbohydrate approach at the age of 15. He is currently working at the Royal Court Health Complex . Prior to that, while working at the Royal Hospital in Muscat, he held the post of an acting consultant in Acute Medicine and ran the Lifestyle Medicine clinic. He also took an active part in teaching medical residents and educating doctors on treatment of Diabetes and other endocrinology disorders. His medical interests are in the fields of Lifestyle Medicine, Integrative Medicineand Endocrinology.
Consultant Family Medicine
Sultanate of Oman
Dr. Nada Al Sumri, MD, MRCGP (INT), is a consultant of family medicine at the directorate general of primary health care in Oman. She received her education at the college of medicine at Sultan Qaboos University in Oman (1997- 2004). Then completed her family medicine residency program at Oman Medical Specialty Board in 2010 and this was followed by one-year clinical training in diabetes care at King Saud University diabetes center in Riyadh, KSA. She holds the position of head of non-communicable diseases section at the department of non-communicable diseases at the ministry of health in Oman. She is also a trainer in the family medicine residency program at Oman Medical Specialty Board. In addition to her clinical experience, she has been involved in developing National non communicable diseases plan and National clinical management manuals on diabetes and hypertension for the primary health care. In addition, she has interest in research in the field of diabetes and primary health care.
Professor of Medicine, Dubai Medical College
Head of insurance medical regulation, DHA, Dubai, United Arab Emirates
Dr. Mohamed Farghaly is a highly experienced physician who worked in United Arab Emirates for around 30 years, he worked as a doctor in charge in al-Mankhool Center, Dubai for around 3 years, then he worked as senior community Physician in charge in the Al Safa health center, Dubai for 11 years, in 2002, he was in charge as manager of the region 4 in primary health care in the department of health and medical service in additional to his clinical duty, in 2006 was allocated to be the head of chronic care unit. In 2014 he got reallocated to be the head of insurance medical regulation, Dubai health authority. Beside that Dr. Farghaly is having also a long academic career such as the following: Senior Lecturer in Dubai Medical College. Tutor for diabetes diploma Leicester UNI. Trainer for Arab Gulf University- Bahrain’s medical students during their Family Medicine clerkship in Dubai – UAE. Trainer for family medicine residents during their residency program training in PHC. Coordinator of Continued education for Diabetic case managers Accredited Trainer in Family Medicine by the Royal College of General Practitioners UK. Accredited Examiner for MRCGP (INT). Deputy Coordinator of the OSCE module of the MRCGP (INT) which has three components: Simulated Surgeries, Orals, and clinical Skills Examination. Member of the Video module of MRCGP (INT) in Dubai Conducting continuous Diabetes Audit (ABC for all PHC year 2003/2004/2007).
Qualifications: MBChB, MSc (Cardiology), MD (USA)
Specialty: Senior Consultant Interventional Cardiologist
Dr. Mohammed El-Deeb, Senior Consultant Interventional Cardiologist comes with more than 25 years of rich experience in the practice of cardiology and has a Fellowship from the American College of Cardiology. He is also one of the main Founders of the Muscat Cardiology Club.
He is a member of the Steering Committee for American College of Cardiology and American Heart Association and is one of the most experienced Interventional Cardiologists in Oman. He is experienced in handling a wide range of Cardiology cases including Acute Coronary Syndromes, Acute Heart Attack, Cardiogenic Shock and Cardiac Arrest. His main interest is Primary Angioplasty for Acute Myocardial Infarction.
Dr. Bassam Saleh Bin-Abbas is a Consultant in the Section of Endocrinology and Diabetes, Department of Pediatrics at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. He is also a Professor of Pediatrics and Endocrinology at the Al-Faisal University. In the USA, he obtained certification at the American Board of Pediatrics after completing his residency program at Yale University in 1997 and American Board of Pediatric Endocrinology after his fellowship training at UCSF/Stanford University in 1999.
M.D. MSc MHPE FRCP(C) DipABPN DipUCNS
Psychiatry Department, Faculty of Medicine, Health Sciences, Kuwait University
Dr Ahmed Al Sajwani completed his board training in Internal Medicine; rotating in The Sultanate major hospitals during which he achieved his membership from the Royal College of Physicians ( Ire).
He was then incorporated in local fellowship program in Diabetes and Endocrinology at Royal Hospital and SQUH.
Driven by his passion, Dr Al Sajwani carried out his fellowship training abroad in the field of Endocrinology and Diabetes from hospitals affiliated with Trinity College and University of Galway in Ireland.
There, along with his clinical attachment and duties. Dr Al Sajwani participated and presented in number of major events linked to his specialty. He was involved in number of research activities at both clinical and laboratory levels, he is one of the authors of a book published recently : advanced practice in Endocrinology Nursing”.
Currently Dr Al Sajwani works as a consultant in Medicine, Endocrinology and Diabetes at Al Nahdha Hospital and Muscat Private Hospital.
Chief Medical Officer, Dasman Diabetes Institute
Consultant Diabetes, Endocrinology and Nutrition
President, American Association of Clinical Endocrinologist-Gulf Chapter
Dr. Ebaa Al-Ozairi is chief medical officer at Dasman Diabetes Institute, a consultant diabetes, endocrine and nutrition and president of the American Association of Clinical Endocrinologist-Gulf Chapter. Ebaa has completed her intercalated BMSc (hons) in molecular pathology at Dundee University (UK) and graduated from Aberdeen University (UK) for her medical undergraduate studies. She then joined Newcastle University (UK) for her specialist training in diabetes and endocrinology. During her postgraduate studies in UK, Ebaa was awarded The Fulbright fellowship to Joslin Diabetes Institute, affiliates of Harvard Medical School, Boston, USA.
Dr. Al-Ozairi's research interest includes obesity, diabetes education, technology, and metabolic surgery. Ebaa has been accredited by the Royal College of Physician (UK) as a medical educator and is an associate practitioner at the UK Higher Education National Academy having completed teaching fellowship. Dr. Al-Ozairi has completed her Rabkin Fellowship in medical education at Harvard Medical school. Ebaa has completed her fellowship in obesity and holds the American Board for Physician Nutrition Specialist and is a fellow at the American College of Nutrition. She also directs DAFNE type 1 diabetes education program and currently granted the training centre for the Middle East. Dr. Al-Ozairi is a reviewer for Diabetic Medicine, Obesity surgery, Practical International Diabetes, and Clinical Endocrinology. She has four chapters in international books and an author in Medscape, Bariatric Times and Endodiabology and has several publications. Dr. Alozairi has won His Highness the Amir Gold Medal Electronic Award and the Arab regional award for e-technology for co-founding the most comprehensive Arabic Diabetes Website.
Shahzad is an experienced National Clinical Lead for complex transformation, clinical informatics programmes (both primary and secondary) at local, regional and national levels. He is the National Clinical Lead for Digital Child Health, a Fellow of the Faculty of Clinical Informatics, and a member of the GDE Blueprinting Steering Group. More recently a National Clinical Lead within the Digital Medicines domain leading on FMD, Med Data, Med Interoperability and Secondary Care Referral programmes.
Previously a Clinical Informatics Lead for a HIMSS Level 6 Academic US affiliated hospital, led the implementation of Cerner Millennium EPR, interoperability and automation for a state-of-the-art digital US Weil Cornell affiliated Academic and Medical Research hospital, the Sidra Medical and Research Centre ($7.9bn endowment fund). Prior to that he was the national clinical lead for the first three pharmacy systems to gain Electronic Prescription Service accreditation and sat on the EPS National Board advising teams nationally about EPS. He has led implementations in the NHS for 15 years providing clinical expertise, clinical risk management, clinical assurance, and creation of Clinical Safety Cases and clinical artefacts e.g. hazard logs. His experience ranges from providing policies contributing to national frameworks and national solutions, also of designing, implementing and optimizing digital solutions.
Pediatric Endocrinologist, Senior Specialist
Department of Pediatrics, Al-Amiri Hospital
Ministry of Health (Kuwait)
Degrees, Diplomas, Licensures and Certifications
1996 Irish Leaving Certificate
1996 – 2003 L.R.C.P & S.I, M.B, Bch., B.A.O
Royal College of Surgeons In Ireland (Medical school),
2010 FRCPC, Canadian Pediatric Residency Program,
University of Toronto (Sickkids hospital),
2010-2012 Pediatric Endocrinology and Metabolism Residency,
University of Toronto,
2012-2013 Pediatric Endocrinology and Metabolism clinical fellowship,
University of Toronto,
2011-2013 Clinical Teacher Certificate
University of Toronto
Dr. Essam M. Abdelalim (Scientist at QBRI & Assistant Professor at HBKU) has 20 years of experience in the field of cell biology, where most of his research has focused on stem cells. He received his Ph.D. in Medical Science from Shiga University of Medical Science (Japan) and was later appointed as Assistant Professor in the same university. Dr. Abdelalim has received several prestigious awards, including the State Prize of Encouragement (Egypt) in 2012 and the President’s Award from Shiga University of Medical Science (Japan) in 2007. He serves on the editorial board of “Stem Cells and Development” and “World Journal of Stem Cells” and serves as a reviewer for several funding agencies. Since April 2014, Dr. Abdelalim has been leading the diabetes stem cell research at QBRI/HBKU. His current research at QBRI focuses on using human pluripotent stem cells (hPSCs) to investigate the molecular mechanisms underlying inherited forms of diabetes and insulin resistance as well as generation of functional pancreatic beta cells for cellular therapy. He is currently leading several projects funded by QBRI/HBKU and Qatar National Research Fund (QNRF). As a faculty member at College of Health and Life Sciences (CHLS) at HBKU, Dr. Abdelalim is coordinating the course of “Stem Cell Biology” and supervises several master and PhD students.
Dr Hassanein is a senior consultant in Endocrinology and Diabetes at Dubai Hospital, Dubai, UAE since 2014. He holds an Academic post of Senior Lecturer, and Associate Director for Postgraduate Diabetes Education, Cardiff University. UK since 2007and was appointed to the post of Consultant in the Department of Endocrinology and Diabetes at BCUHB, UK, in 2002. Dr Hassanein graduated from the Faculty of Medicine, Alexandria, Egypt.
His main research interest is in the field of diabetes and Ramadan. He co-authored recommendations papers on this subject for the American Diabetes Association (ADA) in 2005 and 2010, and for the British Medical Journal in 2010 as well as the IDF-DAR practical guidelines, 2016. Dr Hassanein has participated as the first author and/or a co-author in numerous studies in this field. He has published over 50 papers and has presented more than 30 oral presentations at national and international meetings.
FACH ARZT FUER INNERE MEDIZINE, Germany
(M.D, German Board of Internal Medicine)
(Fellow of the Royal College of Obstetricians and Gynecologist, UK)
Member of The German Association for Physicians
Member of The American Diabetes Association (ADA)
Member of North American Society of Obstetric Medicine (NASOM)
Member and Middle East Representative of International Society of Obstetric Medicine (ISOM)
Member of the Sudanese Association for Physicians
Honorary Member of Sudanese Society for Obs/Gynae
Member of UAE Medical Association
Graduated as MD/ Internal medicine (internist), in Germany. Received specialist training ,and attached to some hospitals, in Germany and UK worked in Sudan till reached the position of Consultant Physician. Joined Medical service in Abu Dhabi ,UAE as Senior Specialist Physician in both The Central Hospital and Al Jazeera Hospital. Joined the largest maternity hospital in the UAE as Consultant Physician, and established there the first unit of Obstetric Medicine in the Middle East and succeeded in making it the first U.K. recognized unit outside U.K. Chaired the Obstetric Medicine Dept, Corniche Hospital, for 25 years dealing with medical problems pre-dating, during or after pregnancy, holding several combined clinics with Obstetricians and specialized physicians in Neurology, Cardiology, Respiratory medicine and Hematology. Held combined clinics with Obstetricians on Diabetes and other endocrine problems predating, during after Pregnancy as well as Preconception clinics for patients who are planning fertility treatment. Delivered more than 300 hundred lectures, scientific talks, and workshops and published more than twenty papers, as author or co-author, on medical problems in pregnancy, in particular DM and other endocrine problems in, or outside, pregnancy. Organized, and participated in professional, regional, and international conferences on Medical issues, particularly on diabetes, Obstetric Medicine issues, and medical disorders in pregnancy.
MBBS, FRCP, CCST (General Medicine, Diabetes and Endocrinology), DPhil (Oxon)
Consultant Diabetologist and Endocrinologist, Bariatric Physician and Clinical lead for the genetics of Diabetes and Endocrinology, Imperial College London Diabetes Centre, Abu Dhabi, UAE
Honorary Senior Lecturer, Imperial College University, London, UK
Dr Sara received her specialist clinical and research training at the world-renowned Oxford Centre for Diabetes, Endocrinology and Metabolism.
Her career has been shaped by her interest in genetic endocrine disorders (particularly in Diabetes and Obesity), physiology, insulin resistance and obesity.
She was awarded a prestigious Diabetes-UK Clinical Research Training Fellowship culminating in a PhD from Oxford University. Dr Suliman has authored several papers, contributed to the Oxford Handbook for Diabetes and Endocrinology and is a reviewer for leading medical journals. She is a founding member of the Imperial Diabetes Educator course since 2013, and a key member of the MRCP PACES course run by ICLDC since 2015.
Dr Suliman Leads the genetic service at ICLDC and is part of the bariatric team, who treat the whole spectrum of obesity ranging from lifestyle measures to medication to surgery.
Awad Mataria is a Regional Adviser at the Eastern-Mediterranean Regional Office (EMRO) of the World Health Organization. He is a pharmacist by training and has a Masters in Health System Analysis from the Université de Rennes I – Rennes/France, and a Ph.D. in Health Economics from the Université de la Méditerranée – Marseille/France. He also did part of his training at the Université de Lyon I – Lyon/France, and at the National School of Public Health – Rennes/France. Dr. Mataria’s areas of expertise cover research in economic evaluation of health care interventions (cost-effectiveness analysis, cost-utility analysis and cost-benefit analyses); Universal Health Coverage; Social Health Insurance; using economics in health care priority setting, financing and organization of health care systems; measuring the benefits of health care mainly using stated preferences techniques; and National Health Accounts. He has presented in several regional and international conferences and has published his work in various reputed Journals of high impact: e.g., Journal of Health Economics, Health Economics, The Lancet, Health Policy, European Journal of Health Economics, Social Science & Medicine, Applied Health Economics and Health Policy, Expert Review of Pharmacoeconomics & Outcomes Research, and Pharmacoepidemiology & Drug Safety.
SBIM. JBIM, FRCP (UK), FACP, FACE
Endocrine Fellowship, University of Calgary, Canada
Endocrinology and Metabolism
Department of Medicine, King Abdulaziz Hospital
Al Ahsa, Saudi Arabia